Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Pascoal

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Blood Advances|July 3, 2023
Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care testsHalimat S Olaniyan, Christine Briscoe, Margarida Muhongo, et al.
Journal of Alzheimer'S Disease : JAD|April 20, 2011
Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairmentInês Baldeiras, Isabel Santana, Maria Teresa Proença, et al.
Journal of Alzheimer'S Disease : JAD|September 11, 2008
Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's diseaseInês Baldeiras, Isabel Santana, Maria Teresa Proença, et al.
Multiple Sclerosis and Related Disorders|January 21, 2017
Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the diseaseAna Valado, Maria João Leitão, António Martinho, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2017
Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's DiseaseAntónio José Gabriel, Maria Rosário Almeida, Maria Helena Ribeiro, et al.
Neuroscience Letters|January 22, 2017
Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patientsAntónio José Gabriel, Maria Rosário Almeida, Maria Helena Ribeiro, et al.
Journal of the Neurological Sciences|September 22, 2015
Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's DiseaseInês Baldeiras, Isabel Santana, Maria João Leitão, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairmentInês Baldeiras, Isabel Santana, Maria João Leitão, et al.
The Neurologist|March 1, 2021
Phospholipase A2 and Ischemic Stroke EtiologyJoana Ramos-Lopes, Ricardo Varela, Rui Pascoal, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Blood Advances|July 3, 2023
Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care testsHalimat S Olaniyan, Christine Briscoe, Margarida Muhongo, et al.
Journal of Alzheimer'S Disease : JAD|April 20, 2011
Oxidative damage and progression to Alzheimer's disease in patients with mild cognitive impairmentInês Baldeiras, Isabel Santana, Maria Teresa Proença, et al.
Journal of Alzheimer'S Disease : JAD|September 11, 2008
Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's diseaseInês Baldeiras, Isabel Santana, Maria Teresa Proença, et al.
Multiple Sclerosis and Related Disorders|January 21, 2017
Multiple sclerosis: Association of gelatinase B/matrix metalloproteinase-9 with risk and clinical course the diseaseAna Valado, Maria João Leitão, António Martinho, et al.
Journal of Alzheimer'S Disease : JAD|December 20, 2017
Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's DiseaseAntónio José Gabriel, Maria Rosário Almeida, Maria Helena Ribeiro, et al.
Neuroscience Letters|January 22, 2017
Association between butyrylcholinesterase and cerebrospinal fluid biomarkers in Alzheimer's disease patientsAntónio José Gabriel, Maria Rosário Almeida, Maria Helena Ribeiro, et al.
Journal of the Neurological Sciences|September 22, 2015
Cerebrospinal fluid Aβ40 is similarly reduced in patients with Frontotemporal Lobar Degeneration and Alzheimer's DiseaseInês Baldeiras, Isabel Santana, Maria João Leitão, et al.
Alzheimer'S Research & Therapy|March 22, 2018
Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairmentInês Baldeiras, Isabel Santana, Maria João Leitão, et al.
The Neurologist|March 1, 2021
Phospholipase A2 and Ischemic Stroke EtiologyJoana Ramos-Lopes, Ricardo Varela, Rui Pascoal, et al.
Pageof 1